ArticleRadiation oncology (London, England)2017

Intermediate-term outcome after PSMA-PET guided high-dose radiotherapy of recurrent high-risk prostate cancer patients.

Sebastian Zschaeck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.